Prescription Weight Loss Medications: Comparing the Options
Prescription weight-management medicines work through different mechanisms. Some reduce appetite or increase fullness, while another limits the absorption of dietary fat. A useful comparison starts with your health needs, possible interactions, and the treatment you can maintain rather than a ranking of the strongest products.
Medication can form part of long-term obesity care. It should come with a plan for nutrition, physical activity, side effects, access, and follow-up. The right prescription for one person may create unacceptable risks or practical problems for another.
Who may benefit from medical treatment
A clinician considers weight-related health problems, body mass index, previous treatment, and the expected balance of benefits and risks. Common adult prescribing criteria include obesity or overweight with a qualifying weight-related condition, but the exact indication belongs to the specific product.
BMI helps organize the assessment; it does not describe every aspect of body composition or health. Blood pressure, glucose, sleep apnea, joint symptoms, medicines, eating patterns, and other concerns can influence what treatment aims to achieve.
Tell the clinician about previous weight change without reducing the history to whether you tried hard enough. Appetite regulation, illness, medication effects, sleep, finances, and access to food or activity can all shape the problem. A plan needs to address practical constraints as well as prescribing criteria.

Appetite and fullness medicines
GLP-1 receptor agonists mimic activity of a hormone involved in appetite and blood sugar regulation. Liraglutide and semaglutide are examples. Tirzepatide acts on both GIP and GLP-1 receptors and belongs in a related, but not identical, treatment category.
These medicines can reduce hunger, increase satisfaction after eating, and slow stomach emptying. They do not simply make the body produce more GLP-1. Their effect on appetite can make changes in eating easier for some people, but reduced intake still needs to provide adequate nutrition.
Product names, approved uses, devices, and doses differ. Wegovy and Ozempic both involve semaglutide, yet a prescription for one cannot automatically substitute for the other. Diabetes treatment and chronic weight management have distinct product-specific indications.
Common digestive effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Gradual dose escalation may improve tolerability. Severe persistent abdominal pain, inability to keep fluids down, or signs of dehydration need assessment rather than an automatic increase to the next dose.
Orlistat reduces fat absorption
Orlistat works in the digestive tract to reduce absorption of some dietary fat. A prescription formulation and a lower-dose nonprescription formulation exist, with different instructions and eligibility requirements. It does not act on hunger in the same way as an appetite medicine.
Oily spotting, gas with discharge, fatty stools, urgency, and difficulty controlling bowel movements can occur. The amount of dietary fat can influence these effects. Ask how to distribute food intake rather than interpreting the medicine as permission to eat unlimited high-fat meals.
The medicine can affect absorption of fat-soluble vitamins and interact with other drugs. A clinician or pharmacist can explain whether and when to take a multivitamin and how to handle other prescriptions. Malabsorption problems and cholestasis are among the conditions that can rule it out.
Orlistat may suit some people for whom another drug's appetite or cardiovascular effects pose a problem, but that does not make it risk-free. Bring the full health and medicine history to the comparison.
Short-term appetite suppressants
Phentermine and some related medicines act on appetite pathways. Phentermine has a short-term weight-management indication and can cause a faster heart rate, dry mouth, insomnia, nervousness, or constipation. Its stimulant-like effects can matter when someone already struggles with palpitations or sleep.
Heart disease, uncontrolled blood pressure, hyperthyroidism, glaucoma, recent use of certain antidepressants, and other circumstances can make treatment unsuitable. The clinician needs the specific diagnosis rather than a general statement that your thyroid or blood pressure sometimes causes problems.
Phentermine is a controlled medicine. Take only your prescription and do not share it, add an energy supplement, or increase the dose to counter a slowing response. Any proposed longer-term use requires a discussion of the evidence, the prescribing context, and monitoring rather than an assumption that a short-term label covers every schedule.
Combination medicines require combined precautions
Phentermine-topiramate combines ingredients with different actions. The product has its own dosing, escalation, monitoring, and stopping instructions. Pregnancy risk, mood or cognitive effects, glaucoma, thyroid conditions, and other health issues need review before treatment.
Naltrexone-bupropion acts on pathways involved in appetite and eating behavior. It does not suit everyone, including people with certain seizure risks or uncontrolled hypertension. Opioid use is particularly relevant because naltrexone can interfere with opioid treatment and cause problems in someone dependent on opioids.
Tell the prescriber about antidepressants, medicines for pain, substance use, and previous reactions. Do not combine separate tablets to recreate a branded product or abruptly stop a regimen that needs a specific withdrawal plan.
A combination name does not mean that each ingredient carries a weight-loss indication on its own. The formulation and the evidence for the actual product matter.
Medicines for another condition are not interchangeable substitutes
Metformin can influence weight in some people while treating diabetes or another condition for which a clinician uses it. That does not make it a universal equivalent to an approved chronic weight-management medicine.
A clinician may also consider changing a medicine that contributes to weight gain, provided another option can treat the original condition appropriately. Do not stop a psychiatric, hormonal, or diabetes medicine yourself because weight has changed.
Ask whether a proposed prescription treats obesity directly, another diagnosed condition, or an off-label need. That distinction helps you understand expected benefit, evidence, insurance coverage, and the monitoring plan.
Compare the practical differences
| Approach | Main action | Questions to discuss |
|---|---|---|
| GLP-1 or related incretin treatment | Influences appetite, fullness, glucose, and digestion | Which product and indication fit, and how will digestive effects affect eating? |
| Orlistat | Reduces absorption of some dietary fat | How should meals, vitamins, and other medicines fit the schedule? |
| Short-term appetite suppressant | Reduces appetite through central signaling | Do cardiovascular, sleep, interaction, or misuse concerns change the choice? |
| Combination medicine | Uses more than one mechanism | Which precautions and stopping instructions apply to the complete product? |
Expected average weight change provides one comparison, but it should not outrank safety, tolerability, and access. A medicine that you cannot obtain regularly or tolerate at an effective dose may not provide the benefit suggested by a trial average.
Check contraindications and interactions before the first dose
Bring a list of prescriptions, supplements, vitamins, and products used only occasionally. Several medicines can affect blood pressure, mood, seizures, glucose, or drug metabolism. A nonprescription weight-loss product still counts in that review.
Discuss pregnancy, pregnancy plans, and breastfeeding before treatment. Weight-loss medicines do not provide a pregnancy treatment plan, and stopping intervals can vary by product. Do not borrow another person's instructions.
For medicines with a thyroid C-cell tumor warning, the relevant history includes medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2. That differs from all thyroid disease. Kidney problems, pancreatitis history, severe gastrointestinal symptoms, and other conditions also need product-specific consideration.
Keep food and activity in the treatment plan
A lower appetite can help reduce intake, but it can also make it easy to miss protein, fiber, fluids, or regular meals. A dietitian can help you plan eating around nausea, fullness, food preferences, and medical restrictions without creating an unnecessarily narrow diet.
Physical activity supports fitness, strength, glucose regulation, and function even when the scale changes slowly. Resistance work can help preserve strength during weight loss. Choose an activity level that fits your ability and medical circumstances rather than treating exercise as punishment.
Behavioral support can address emotional eating, planning, sleep, and barriers to maintaining a routine. Coaching can support goals, but it does not replace care for an eating disorder, depression, or another mental health condition.
Agree on monitoring and a long-term decision
Ask what improvement would justify continuing, when to assess it, and which adverse effects should prompt a call. Stopping rules differ between products and doses; one generic deadline does not fit every prescription.
Follow-up may include weight, blood pressure, pulse, glucose where relevant, nutrition, symptoms, and the effect on daily function. Report persistent vomiting, severe abdominal pain, concerning mood changes, or other new symptoms instead of waiting for a routine refill.
Discuss cost and access before interruptions occur. If treatment stops, appetite and weight may change again. Plan the next step with the prescriber, including any dose reduction or restart instructions, rather than repeatedly cycling through leftover medicines.
Sources
- National Institute of Diabetes and Digestive and Kidney Diseases. Prescription Medications to Treat Overweight and Obesity. https://www.niddk.nih.gov/health-information/weight-management/prescription-medications-treat-overweight-obesity
- Novo Nordisk. Ozempic prescribing information. https://www.novo-pi.com/ozempic.pdf
- Novo Nordisk. Wegovy prescribing information. https://www.novo-pi.com/wegovy.pdf
Related reading
- GLP-1 Medications: Uses, Effects, and Questions Before Treatment
- Ozempic vs. Wegovy: What the Shared Ingredient Does Not Tell You
- Health Guide
Medical Disclaimer: This content is provided for informational and educational purposes only and does not constitute personalized medical advice, diagnosis, or treatment. Always consult a qualified physician or licensed healthcare provider with any questions regarding a medical condition or prescription medication. Read our Editorial & Medical Review Policy.
